Composition for treatment of inflammatory disorders
CA 2489269 C · Owner: Metselaar, Josbert Maarten · Inventors: Metselaar, Josbert Maarten
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition for parenteral administration comprising , liposomes composed of non-charged vesicle-forming lipids optionally including , not more than 5 mole percent of charged vesicle-forming lipids the liposomes , having a selected mean particle diameter in the size range between about 40 - 200 nm and containing a water soluble corticosteroid for the site-specific treatment of inflammatory disorders, is provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 11, 2003 and granted January 17, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 11, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 11, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.